-
1 Comment
Olympus Corporation is currently in a long term downtrend where the price is trading 1.2% below its 200 day moving average.
From a valuation standpoint, the stock is 94.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.
Olympus Corporation's total revenue sank by 4.3% to $197B since the same quarter in the previous year.
Its net income has increased by 5.4% to $24B since the same quarter in the previous year.
Finally, its free cash flow grew by 78.1% to $42B since the same quarter in the previous year.
Based on the above factors, Olympus Corporation gets an overall score of 3/5.
Exchange | TSE |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
CurrencyCode | JPY |
ISIN | JP3201200007 |
Market Cap | 2T |
---|---|
PE Ratio | 22.06 |
Target Price | 2704.4214 |
Dividend Yield | 2.1% |
Beta | 0.59 |
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7733.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025